The Patent Finder

1H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors

H. Lundbeck A/S

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 15/637,920, filed Jun 29, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,034,8611H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
In force
 · High confidence
UsedRemaining
H. Lundbeck A/SIn forceHigh confidence
US 10,512,6321H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
US 10,806,7181H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
US 11,026,9231H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
In force
 · Medium confidence
H. Lundbeck A/SIn forceMedium confidence
US 11,026,9241H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
In force
 · Medium confidence
H. Lundbeck A/SIn forceMedium confidence
US 11,491,1401H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
Application 16/999,2471H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
Abandoned
Abandoned Mar 31, 2023
H. Lundbeck A/SAbandonedAbandoned Mar 31, 2023
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by H. Lundbeck A/S.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited